LankesterACAlbertMHBoothC, et al. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052-2062. doi:10.1038/s41409-021-01378-8.
2.
CorbaciogluSHönigMLahrG, et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant. 2006;38(8):547-553. doi:10.1038/sj.bmt.1705485.
OrkinSHNathanDGGinsburgDLookATFisherDELuxS.Inherited bone marrow failure syndromes. In: OrkinSHNathanDGGinsburgDLookATFisherDELuxS, eds. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood, 8th ed.Amsterdam: Elsevier; 2014:182-253.
5.
KaplanFSAugustCSFallonMDGannonFHaddadJG.Osteopetrorickets: the paradox of plenty—pathophysiology and treatment. Clin Orthop Relat Res. 1993;294:64-78.
6.
WuCCEconsMJDiMeglioLA, et al. Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab. 2017;102(9):3111-3123. doi:10.1210/jc.2017-01127.
7.
DriessenGJGerritsenEJFischerA, et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003;32(7):657-663. doi:10.1038/sj.bmt.1704194.
8.
KeyLLJrRiesWLRodriguizRMHatcherHC.Recombinant human interferon gamma therapy for osteopetrosis. J Pediatr. 1992;121(1):119-124. doi:10.1016/s0022-3476(05)82557-0.
9.
KeyLLJrRodriguizRMWilliSM, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med. 1995;332(24):1594-1599. doi:10.1056/NEJM199506153322402.
10.
MoscatelliIAlmarzaESchambachA, et al. Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal. Mol Ther Methods Clin Dev. 2020;20:389-397. doi:10.1016/j.omtm.2020.12.009.
